Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.

POORER dementia sufferers in England are “less likely to get key drugs,” according to research published yesterday. The University College London study found stark differences in patient access to key ...

SGLT-2 inhibitors were associated with the lowest risk for incidental dementia relative to DPP-4 inhibitors and GLP-1RAs in type 2 diabetes.

RESEARCHERS have developed a drug that successfully blocks two major Alzheimer’s disease “hotspots” at once, in a “promising” breakthrough against the brain robbing ...

This may be another reason why it’s best to start treatment as soon as ... the potential to form the basis for future anti-dementia drugs, particularly for people at increased risk of developing ...

What’s the best breakfast for dementia? The paper found that study participants who ate one egg a day were less likely to ...

Dementia is a devastating disease that impacts one in 10 older Americans. But while many people want to avoid developing ...

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed ... Yet to the consternation of some dementia experts, simufilam remains in advanced clinical trials.

Eggs can be part of a brain-healthy diet that cuts dementia risk ... of Aging and Alzheimer’s Prevention at the Alzheimer’s Drug Discovery Foundation. She stressed that participants who ...

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

Additional Money for Dementia-Related Respite Care . A new Medicare program called Guiding an Improved Dementia Experience ...